Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine in cirrhotic patients with refractory ascites
PACTR202306748777678Completed
- Sponsor
- Tanta University Hospitals
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of midodrine in ascites and Cirrhosis (2 arms), sponsored by Tanta University Hospitals. Primary endpoints: Effect on body weight, Effect on abdominal girth and 1 more. Started Mar 2021; status: completed.
02
Drugs
midodrine
03
Conditions
ascitesCirrhosis
Beyond the preview
Go deeper on PACTR202306748777678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202306748777678.